OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 2415 citing articles:

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1452

Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease
Kunihiro Matsushita, Shoshana H. Ballew, Angela Yee‐Moon Wang, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 11, pp. 696-707
Closed Access | Times Cited: 314

Health and related indicators 2021
Noluthando Ndlovu, Andy Gray, Bonga Mkhabela, et al.
South African Health Review (2022) Vol. 24
Open Access | Times Cited: 265

Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission
Valery L. Feigin, Mayowa Owolabi, Valery L. Feigin, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 12, pp. 1160-1206
Open Access | Times Cited: 188

Projected Global Trends in Ischemic Stroke Incidence, Deaths and Disability-Adjusted Life Years From 2020 to 2030
Liyuan Pu, Li Wang, Ruijie Zhang, et al.
Stroke (2023) Vol. 54, Iss. 5, pp. 1330-1339
Open Access | Times Cited: 181

Primary stroke prevention worldwide: translating evidence into action
Mayowa Owolabi, Amanda G. Thrift, Ajay Mahal, et al.
The Lancet Public Health (2021) Vol. 7, Iss. 1, pp. e74-e85
Open Access | Times Cited: 159

Sex differences in arterial hypertension
Eva Gerdts, Isabella Sudano, Sofie Brouwers, et al.
European Heart Journal (2022) Vol. 43, Iss. 46, pp. 4777-4788
Open Access | Times Cited: 139

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
Markus P. Schlaich, M Bellet, Michael A. Weber, et al.
The Lancet (2022) Vol. 400, Iss. 10367, pp. 1927-1937
Open Access | Times Cited: 130

Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease
Michel Burnier, Aikaterini Damianaki
Circulation Research (2023) Vol. 132, Iss. 8, pp. 1050-1063
Closed Access | Times Cited: 129

The gut microbiome and hypertension
Joanne A. O’Donnell, Tenghao Zheng, Guillaume Méric, et al.
Nature Reviews Nephrology (2023) Vol. 19, Iss. 3, pp. 153-167
Closed Access | Times Cited: 127

Endovascular Ultrasound Renal Denervation to Treat Hypertension
Michel Azizi, Manish Saxena, Yale Wang, et al.
JAMA (2023) Vol. 329, Iss. 8, pp. 651-651
Open Access | Times Cited: 111

Reactive Oxygen Species Scavenging Nanomedicine for the Treatment of Ischemic Heart Disease
Zhan Zhang, Rinkoo Dalan, Zhenyu Hu, et al.
Advanced Materials (2022) Vol. 34, Iss. 35
Open Access | Times Cited: 101

Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions
Jun Ma, Yanan Li, Xiangyu Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 99

A village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trial
Yingxian Sun, Jianjun Mu, Dao Wen Wang, et al.
The Lancet (2022) Vol. 399, Iss. 10339, pp. 1964-1975
Closed Access | Times Cited: 94

Hypertension management in patients with cardiovascular comorbidities
Lucas Lauder, Felix Mahfoud, Michel Azizi, et al.
European Heart Journal (2022) Vol. 44, Iss. 23, pp. 2066-2077
Open Access | Times Cited: 94

Uric Acid and Hypertension: a Review of Evidence and Future Perspectives for the Management of Cardiovascular Risk
Claudio Borghi, Davide Agnoletti, Arrigo F.G. Cicero, et al.
Hypertension (2022) Vol. 79, Iss. 9, pp. 1927-1936
Open Access | Times Cited: 93

Chlorthalidone vs. Hydrochlorothiazide for Hypertension–Cardiovascular Events
Areef Ishani, William C. Cushman, Sarah Leatherman, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 26, pp. 2401-2410
Open Access | Times Cited: 89

Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension
Fadi J. Charchar, Priscilla R. Prestes, Charlotte Mills, et al.
Journal of Hypertension (2023) Vol. 42, Iss. 1, pp. 23-49
Open Access | Times Cited: 86

Cancer Therapy–Related Hypertension: A Scientific Statement From the American Heart Association
Jordana B. Cohen, Nancy J. Brown, Sherry‐Ann Brown, et al.
Hypertension (2023) Vol. 80, Iss. 3
Open Access | Times Cited: 85

Hypertension in China: epidemiology and treatment initiatives
Ji‐Guang Wang, Ying Zhang, Yan Li, et al.
Nature Reviews Cardiology (2023) Vol. 20, Iss. 8, pp. 531-545
Closed Access | Times Cited: 85

Page 1 - Next Page

Scroll to top